CA2252524A1 - Lignees de cellules souches embryonnaires de lapin multipotentes et leur utilisation pour produire des lapins chimeriques - Google Patents
Lignees de cellules souches embryonnaires de lapin multipotentes et leur utilisation pour produire des lapins chimeriques Download PDFInfo
- Publication number
- CA2252524A1 CA2252524A1 CA002252524A CA2252524A CA2252524A1 CA 2252524 A1 CA2252524 A1 CA 2252524A1 CA 002252524 A CA002252524 A CA 002252524A CA 2252524 A CA2252524 A CA 2252524A CA 2252524 A1 CA2252524 A1 CA 2252524A1
- Authority
- CA
- Canada
- Prior art keywords
- cells
- rabbit
- embryonic stem
- medium
- cell lines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 241000283973 Oryctolagus cuniculus Species 0.000 title claims abstract description 76
- 210000002459 blastocyst Anatomy 0.000 claims abstract description 44
- 238000012258 culturing Methods 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 172
- 238000002347 injection Methods 0.000 claims description 23
- 239000007924 injection Substances 0.000 claims description 23
- 239000002609 medium Substances 0.000 claims description 20
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 17
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 13
- 238000010186 staining Methods 0.000 claims description 11
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 10
- 210000001161 mammalian embryo Anatomy 0.000 claims description 10
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 10
- 241001529936 Murinae Species 0.000 claims description 8
- 238000002744 homologous recombination Methods 0.000 claims description 8
- 230000006801 homologous recombination Effects 0.000 claims description 8
- 238000002955 isolation Methods 0.000 claims description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 7
- 102000004058 Leukemia inhibitory factor Human genes 0.000 claims description 7
- 108090000581 Leukemia inhibitory factor Proteins 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- 230000010558 Gene Alterations Effects 0.000 claims description 6
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 6
- 239000002953 phosphate buffered saline Substances 0.000 claims description 6
- 238000012546 transfer Methods 0.000 claims description 6
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 claims description 5
- 101001011741 Bos taurus Insulin Proteins 0.000 claims description 5
- 102000029816 Collagenase Human genes 0.000 claims description 5
- 108060005980 Collagenase Proteins 0.000 claims description 5
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 5
- 241000287828 Gallus gallus Species 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 5
- 229930182816 L-glutamine Natural products 0.000 claims description 5
- 239000004107 Penicillin G sodium Substances 0.000 claims description 5
- 230000005540 biological transmission Effects 0.000 claims description 5
- IXIBAKNTJSCKJM-BUBXBXGNSA-N bovine insulin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 IXIBAKNTJSCKJM-BUBXBXGNSA-N 0.000 claims description 5
- 229960002424 collagenase Drugs 0.000 claims description 5
- 239000003797 essential amino acid Substances 0.000 claims description 5
- 235000020776 essential amino acid Nutrition 0.000 claims description 5
- 239000012091 fetal bovine serum Substances 0.000 claims description 5
- 210000004602 germ cell Anatomy 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 235000019369 penicillin G sodium Nutrition 0.000 claims description 5
- 229940056360 penicillin g Drugs 0.000 claims description 5
- 210000002966 serum Anatomy 0.000 claims description 5
- 229960002385 streptomycin sulfate Drugs 0.000 claims description 5
- 102000013127 Vimentin Human genes 0.000 claims description 3
- 108010065472 Vimentin Proteins 0.000 claims description 3
- 230000002776 aggregation Effects 0.000 claims description 3
- 238000004220 aggregation Methods 0.000 claims description 3
- 230000024245 cell differentiation Effects 0.000 claims description 3
- 210000005048 vimentin Anatomy 0.000 claims description 3
- 102100033421 Keratin, type I cytoskeletal 18 Human genes 0.000 claims description 2
- 108010066327 Keratin-18 Proteins 0.000 claims description 2
- 230000005757 colony formation Effects 0.000 claims description 2
- 238000009795 derivation Methods 0.000 abstract description 13
- 238000012423 maintenance Methods 0.000 abstract description 5
- 238000005457 optimization Methods 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 18
- 210000002257 embryonic structure Anatomy 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 11
- 210000001671 embryonic stem cell Anatomy 0.000 description 9
- 210000002950 fibroblast Anatomy 0.000 description 9
- 230000004069 differentiation Effects 0.000 description 7
- 238000004113 cell culture Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004952 blastocoel Anatomy 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000002308 embryonic cell Anatomy 0.000 description 3
- 208000001608 teratocarcinoma Diseases 0.000 description 3
- 210000000143 trophectoderm cell Anatomy 0.000 description 3
- 206010068051 Chimerism Diseases 0.000 description 2
- 108010058936 Cohn fraction V Proteins 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000288906 Primates Species 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000001857 anti-mycotic effect Effects 0.000 description 2
- 239000002543 antimycotic Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010363 gene targeting Methods 0.000 description 2
- 230000004077 genetic alteration Effects 0.000 description 2
- 231100000118 genetic alteration Toxicity 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 210000000472 morula Anatomy 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 241000700112 Chinchilla Species 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 208000035752 Live birth Diseases 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- 101000803350 Mus musculus Vimentin Proteins 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 208000035199 Tetraploidy Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000005395 beveled glass Substances 0.000 description 1
- 230000029803 blastocyst development Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000032692 embryo implantation Effects 0.000 description 1
- 210000002242 embryoid body Anatomy 0.000 description 1
- 210000001900 endoderm Anatomy 0.000 description 1
- 210000002336 epiblast cell Anatomy 0.000 description 1
- 210000003237 epithelioid cell Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000010196 hermaphroditism Effects 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 230000004777 loss-of-function mutation Effects 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002135 phase contrast microscopy Methods 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229940047883 porcine follicle stimulating hormone Drugs 0.000 description 1
- 210000005238 principal cell Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 1
- 229960001600 xylazine Drugs 0.000 description 1
- 210000004340 zona pellucida Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- C12N15/877—Techniques for producing new mammalian cloned embryos
- C12N15/8777—Rabbit embryos
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Lignée de cellules souches embryonnaires de lapin, qui comprend au moins 70 %, de préférence 80 à 90 %, de cellules indifférenciées et obtenues par isolement de l'amas cellulaire interne de blastocystes 5,5 jours postcoïtus et par culture desdites lignées sur des cellules nourricières dans un milieu pour cellules souches embryonnaires de lapin. La présente invention concerne en outre l'optimisation de la dérivation et de la conservation de ladite lignée cellulaire et l'utilisation de cette dernière entre autres pour produire des lapins chimériques.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96201169 | 1996-04-29 | ||
| EP96201169.8 | 1996-04-29 | ||
| EP96203060 | 1996-11-04 | ||
| EP96203060.7 | 1996-11-04 | ||
| EP97200168.9 | 1997-01-22 | ||
| EP97200168 | 1997-01-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2252524A1 true CA2252524A1 (fr) | 1997-11-06 |
Family
ID=27237546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002252524A Abandoned CA2252524A1 (fr) | 1996-04-29 | 1997-04-29 | Lignees de cellules souches embryonnaires de lapin multipotentes et leur utilisation pour produire des lapins chimeriques |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0907722A1 (fr) |
| JP (1) | JP2000508919A (fr) |
| CN (1) | CN1217746A (fr) |
| AU (1) | AU2892997A (fr) |
| CA (1) | CA2252524A1 (fr) |
| WO (1) | WO1997041209A1 (fr) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0941310A1 (fr) | 1996-10-11 | 1999-09-15 | THE TEXAS A&M UNIVERSITY SYSTEM | Techniques permettant la production de cellules sexuelles primordiales et d'especes animales transgeniques |
| JP2002527036A (ja) * | 1997-11-25 | 2002-08-27 | エイアールシー ジェノミック リサーチ | 多能性胚性幹細胞および多能性胚性幹細胞を得る方法 |
| WO1999027076A1 (fr) * | 1997-11-25 | 1999-06-03 | Arc Genomic Research | Cellules souches embryonnaires multipotentes et procedes permettant de les obtenir |
| US6238922B1 (en) * | 1999-02-26 | 2001-05-29 | Stemcells, Inc. | Use of collagenase in the preparation of neural stem cell cultures |
| KR100771294B1 (ko) * | 1999-12-14 | 2007-10-29 | 써모 바이오스타, 인크. | 폴리펩티드 및 항원 안정화 희석제 |
| JP4795616B2 (ja) * | 2000-06-20 | 2011-10-19 | イーエス・セル・インターナショナル・プライヴェート・リミテッド | Ｂｍｐ−２経路アンタゴニストの存在下においてｅｓ細胞を培養することによって胚性幹細胞の分化をコントロールする方法 |
| EP1217071B1 (fr) | 2000-12-22 | 2010-04-28 | Institut National De La Recherche Agronomique | Expression position-indépendante et tissus-spécifique d' un transgène dans le lait d'animaux transgéniques |
| FR2834518B1 (fr) * | 2002-01-10 | 2005-03-18 | Agronomique Inst Nat Rech | Procede de clonage nucleaire chez le lapin et utilisations |
| US8846393B2 (en) | 2005-11-29 | 2014-09-30 | Gamida-Cell Ltd. | Methods of improving stem cell homing and engraftment |
| EP2508595B1 (fr) | 2009-12-01 | 2016-11-23 | National Cancer Center | Procédé de construction d'un rat chimérique à l'aide de cellules souches embryonnaires de rat |
| US20120244619A1 (en) | 2009-12-09 | 2012-09-27 | Kyoto University | Composition for promoting differentiation of pluripotent stem cells into cardiac muscle cells which comprises nitrovin |
| CN102933074B (zh) | 2010-06-11 | 2015-04-08 | 瑞泽恩制药公司 | 由xy es细胞制备能育的xy雌性动物 |
| US9499790B2 (en) | 2010-08-26 | 2016-11-22 | Kyoto University | Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells |
| CN103209968B (zh) | 2010-08-26 | 2015-08-05 | 国立大学法人京都大学 | 多能干细胞心肌细胞分化促进剂 |
| KR101996343B1 (ko) | 2012-01-27 | 2019-07-05 | 고쿠리츠 다이가쿠 호진 교토 다이가쿠 | 전능성 줄기세포의 심근분화 유도방법 |
| BR112014020119A2 (pt) | 2012-02-13 | 2020-10-27 | Gamida-Cell Ltd | cultura de células-tronco mesenquimais |
| US9175266B2 (en) | 2012-07-23 | 2015-11-03 | Gamida Cell Ltd. | Enhancement of natural killer (NK) cell proliferation and activity |
| US9567569B2 (en) | 2012-07-23 | 2017-02-14 | Gamida Cell Ltd. | Methods of culturing and expanding mesenchymal stem cells |
| EP2966166B1 (fr) | 2013-03-08 | 2019-04-03 | Kyoto University | Promoteur de différenciation d'une cellule souche pluripotente en myocarde, lequel comprend un inhibiteur d'un récepteur d'egf |
| WO2015037706A1 (fr) | 2013-09-13 | 2015-03-19 | 国立大学法人京都大学 | Composé favorisant la différenciation de cellules souches pluripotentes en cardiomyocytes |
| WO2015182765A1 (fr) | 2014-05-30 | 2015-12-03 | 国立大学法人京都大学 | Procédé d'induction de la différenciation myocardique des cellules souches pluripotentes à l'aide d'un composé de faible poids moléculaire |
| HUE041584T2 (hu) | 2014-06-26 | 2019-05-28 | Regeneron Pharma | Célzott genetikai módosítások és alkalmazási módszerek és készítmények |
| CA2998642C (fr) | 2015-09-17 | 2023-09-12 | Regeneron Pharmaceuticals, Inc. | Selection de cellules pluripotentes pour la production de souris femelles xy fertiles |
| CN109153973A (zh) | 2016-03-18 | 2019-01-04 | 国立大学法人京都大学 | 用于冷冻多能干细胞来源心肌细胞的聚集体的方法 |
| CN109609446B (zh) * | 2018-11-14 | 2020-11-03 | 广西大学 | 一种用于分离培养兔胚胎干细胞的培养液和方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2740320B2 (ja) * | 1988-08-04 | 1998-04-15 | アムラド・コーポレイション・リミテッド | 胚幹細胞のインビトロ増殖 |
| US5523226A (en) * | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
-
1997
- 1997-04-29 CA CA002252524A patent/CA2252524A1/fr not_active Abandoned
- 1997-04-29 JP JP9538604A patent/JP2000508919A/ja active Pending
- 1997-04-29 CN CN97194183A patent/CN1217746A/zh active Pending
- 1997-04-29 EP EP97922992A patent/EP0907722A1/fr not_active Withdrawn
- 1997-04-29 WO PCT/EP1997/002323 patent/WO1997041209A1/fr not_active Application Discontinuation
- 1997-04-29 AU AU28929/97A patent/AU2892997A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2892997A (en) | 1997-11-19 |
| JP2000508919A (ja) | 2000-07-18 |
| WO1997041209A1 (fr) | 1997-11-06 |
| CN1217746A (zh) | 1999-05-26 |
| EP0907722A1 (fr) | 1999-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2252524A1 (fr) | Lignees de cellules souches embryonnaires de lapin multipotentes et leur utilisation pour produire des lapins chimeriques | |
| Schoonjans et al. | Pluripotential rabbit embryonic stem (ES) cells are capable of forming overt coat color chimeras following injection into blastocysts | |
| Wheeler | Development and validation of swine embryonic stem cells: a review | |
| Baharvand et al. | Culture condition difference for establishment of new embryonic stem cell lines from the C57BL/6 and BALB/c mouse strains | |
| Strojek et al. | A method for cultivating morphologically undifferentiated embryonic stem cells from porcine blastocysts | |
| Saito et al. | Bovine embryonic stem cell-like cell lines cultured over several passages | |
| Graves et al. | Derivation and characterization of putative pluripotential embryonic stem cells from preimplantation rabbit embryos | |
| US6436701B1 (en) | Derivation of pluripotential embryonic cell lines from ungulate species | |
| Strelchenko | Bovine pluripotent stem cells | |
| Vackova et al. | Putative embryonic stem cell lines from pig embryos | |
| US6107543A (en) | Culture of totipotent embryonic inner cells mass cells and production of bovine animals | |
| Dattena et al. | Isolation, culture, and characterization of embryonic cell lines from vitrified sheep blastocysts | |
| Zhou et al. | In vitro derivation of germ cells from embryonic stem cells in mammals | |
| Sukoyan et al. | Establishment of new murine embryonic stem cell lines for the generation of mouse models of human genetic diseases | |
| US6103523A (en) | Pluripotent rabbit cell lines and method of making | |
| KR101213691B1 (ko) | 전강 난포-유래 배아 줄기 세포 | |
| Anderson | Isolation and use of embryonic stem cells from livestock species | |
| CA2372635A1 (fr) | Processus de reprogrammation cellulaire par production d'un heterocaryon | |
| Mizutani et al. | Propagation of senescent mice using nuclear transfer embryonic stem cell lines | |
| US20070250943A1 (en) | Construction of Chimera Using En Cells | |
| Modliński et al. | Embryonic stem cells: developmental capabilities and their possible use in mammalian embryo cloning | |
| WO1995006716A1 (fr) | Cellules souches pluripotentes d'embryons de rats et leur procede d'obtention et d'utilisation | |
| Anderson | Embryonic stem cells in agricultural species | |
| Strelchenko | Bovine Pluripotent stem cells for transgenic vectors | |
| WO2006083133A2 (fr) | Cellule souche d'embryon humain creee a partir d'un ovocyte et cellule somatique derivee d'individus non identiques, et methode de preparation de celles-ci |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |